Invention Grant
- Patent Title: Variant of antihemophilic factor VIII having increased specific activity
-
Application No.: US14834769Application Date: 2015-08-25
-
Publication No.: US10053500B2Publication Date: 2018-08-21
- Inventor: Chee Kong Lai , Roddy Kevin Stafford
- Applicant: BAXALTA INCORPORATED , BAXALTA GMBH
- Applicant Address: US IL Bannockburn CH Zug
- Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee Address: US IL Bannockburn CH Zug
- Agency: Morgan Lewis & Bockius LLP
- Main IPC: C07K14/755
- IPC: C07K14/755 ; A61K38/00
Abstract:
The present invention is in the field of hemophilia therapy. It relates to a new variant of antihemophilic factor VIII having increased specific activity in comparison to known factor VIII products.
Public/Granted literature
- US20150353625A1 VARIANT OF ANTIHEMOPHILIC FACTOR VIII HAVING INCREASED SPECIFIC ACTIVITY Public/Granted day:2015-12-10
Information query
